Atlas Trials

Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC

Clinical trial NCT05555199 · COMPLETED

Trial details

NCT number
NCT05555199
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Early-stage Lung Cancer
Start date
2022-10-03
Primary completion
2024-10-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.